About this episode
(00:32)
Could you let our listeners know a bit about your role and background at Mayo Clinic?
(01:23)
Is there a lot of information sharing between our neurology clinicians and the Alzheimer’s Disease Research Center when it comes to test development?
(01:50)
Can you give us a brief overview of the test?
(03:17)
Is a cerebral spinal fluid test for NFLC already on the market?
(04:41)
How has Mayo Clinic been able to launch this test in blood?
(05:49)
What is a laboratory developed test, and what does it mean for physicians?
(07:00)
Do we have a high degree of confidence that physicians will get an actionable result from this blood test?
(07:45)
How will Mayo Clinic Laboratories help physicians interpret the test results?
(09:15)
For which patients is this test most appropriate?
(10:59)
How might patients benefit from this test?
(11:46)
How can this test help physicians to know which treatment path to pursue?
(12:33)
How else might this test benefit patients?
(13:49)
What about this test excites you most?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab